NCT01430234View on ClinicalTrials.gov

Enzyme Suppletion in Exocrine Pancreatic Dysfunction

PHASE4CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

February 28, 2013

Study Completion Date

February 28, 2013

Conditions
Chronic PancreatitisExocrine Pancreatic Insufficiency
Interventions
DRUG

Panzytrat 25.000 FIP-E units of Lipase

patients will experiment with Panzytrat (containing 25.000 units of lipase) to a maximum of 16 capsules a day according to general guidelines.

Trial Locations (1)

3000 WB

Erasmus Medical Center, Rotterdam

Sponsors

Collaborators (1)

Axcan Pharma
All Listed Sponsors
collaborator

Axcan Pharma

INDUSTRY

lead

Foundation for Liver Research

OTHER